Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

What Happened: MD's decision to sell 11,659 shares of Collegium Pharmaceutical was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value of the sale ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

Novartis, a New Jersey drug manufacturer, filed the lawsuit in federal court in Portland over the program that allows hospitals and community health centers to get some medications at discount prices.

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...